reports
Eurofins Scientific announces the acquisition of Labormar, further exp...
BARRANQUILLA, Colombia--(BUSINESS WIRE)-- The Eurofins network of companies, a world leader in food, environment, pharmaceutical and cosmetic product testing, announces the completion of the acquisition of Labormar. The acquisition will further strengthen the Eurofins network’s global food and feed, cosmetic and pharmacological, and environmental testing offering and its presence in Latin America. Known as Eurofins Labormar going forward, the laboratory represents the second Eurofins laboratory in Colombia. Headquartered in Barranquilla, Labormar is nationally recognised as a reference labor...
- Carole Braudeau
Credit Morning 07/08/2024
France / elections - sensitivity for banks and insurers Delivery Hero might face € 400 m fine due to alleged antitrust violations Altice International: exclusive negotiations with STC for the sale of Altice Portugal have reportedly broken off (Eco) Grifols: the founding family and Brookfield are said to mull a bid (Cinco Dias) Altice France: the sale process of Xpfibre has reportedly stalled (Bloomberg)>...
- Carole Braudeau
Morning Crédit 08/07/2024
France / élections – sensibilité pour les banques et assureurs Delivery Hero devrait faire face à une amende antitrust de plus de 400 m EUR Altice International : les négociations avec STC pour la vente d’Altice Portugal seraient dans l’impasse (Eco) Grifols : la famille fondatrice et Brookfield envisageraient une OPA (Cinco Dias) Altice France : le projet de vente de Xpfibre serait dans l’impasse (Bloomberg)>...
- Carole Braudeau
- Carole Braudeau
Eurofins provides further refutations to another set of baseless alleg...
LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News: Eurofins (Paris:ERF): In response to the reports by Muddy Waters, LLC (MW) on Eurofins published on 24 June 2024 and 03 July 2024 and expanding on its previous press releases on this subject on 25 June 2024 and 03 July 2024, Eurofins is providing further detailed information to refute the baseless allegations intentionally spread by the short seller MW, further evidencing and supporting Eurofins’ view that the entirety of the allegations and insinuations contained in MW’s reports are either inaccurate, irrelevant, biased and/or misleading. A...
Mercialys se voit décerner le 1er Prix de la Transparence ESG dans le ...
PARIS--(BUSINESS WIRE)-- Regulatory News: Déjà primée à 7 reprises dans cette démarche englobant les sociétés du SBF 120, et au titre du Grand prix de la Transparence Toutes Catégories en 2023, Mercialys (Paris:MERY) a remporté ce jour le 1er prix dans la catégorie Information ESG1. Il récompense les efforts, menés dans le temps long, de la Société en faveur de la clarté et de la complétude de l’information extra - financière. Cette distinction, décernée sur la base de 98 critères rigoureusement évalués par un jury indépendant, porte sur l’information disponible dans le Document d'enregist...
- Carole Braudeau
- Geoffroy Michalet
Eurofins : Eurofins refutes the accusations by MW…which publishes a se...
>Additional information provided by Eurofins concerning real estate… - Eurofins yesterday published a detailed report responding to Muddy Waters’ accusations split into 13 parts... and provided links to a number of data sources to back up its assertions. We will focus on the most important elements: real estate, cash and accounting. Real estate transactions: The group said that 13.9% of the real estate, or 240k m², is owned by related parties for annual rent...
- Carole Braudeau
- Ahmed Ben Salem
- Marc Lavaud
- Thijs Berkelder
ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 07/04/2024
Sartorius is set to outperform the underlying biopharmaceutical market based on higher exposure to novel biologics and its focus on single-use components. Destocking is likely to end soon but the changing ordering pattern could distort order intake as KPI and organic growth should recover faster. In our view, the expected cut to its FY 2024 guidance is already largely reflected in the share price. Based on the expected turnaround, we have upgraded to Outperform with a new target price...
AKRBF AKER BP ASA
FP TOTAL SE
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
SLB.N SCHLUMBERGER NV
RI PERNOD RICARD SA
GTT GAZTRANSPORT & TECHNIGAZ SA
SBMO SBM OFFSHORE NV
EURN EURONAV NV
ADEN ADECCO GROUP AG
PGS PGS ASA
ZAL ZALANDO SE
ENI ENI S.P.A.
P2F PETROFAC LIMITED
REP REPSOL SA
SOC SUBSEA 7 S.A.
SBO SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG
EVK EVONIK INDUSTRIES AG
TRE TECNICAS REUNIDAS SA
DR0 DEUTSCHE ROHSTOFF AG
TEC TECHNIPFMC PLC
BP. BP P.L.C.
CGG CGG
ENOG ENERGEAN PLC
VK VALLOUREC SA
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
TE TECHNIP ENERGIES NV
FUR FUGRO NV
SHEL SHELL PLC
SPM SAIPEM S.P.A.
TEN TENARIS S.A.
- Ahmed Ben Salem
- Marc Lavaud
- Thijs Berkelder
ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 04/07/2024
Sartorius is set to outperform the underlying biopharmaceutical market based on higher exposure to novel biologics and its focus on single-use components. Destocking is likely to end soon but the changing ordering pattern could distort order intake as KPI and organic growth should recover faster. In our view, the expected cut to its FY 2024 guidance is already largely reflected in the share price. Based on the expected turnaround, we have upgraded to Outperform with a new target price...
AKRBF AKER BP ASA
FP TOTAL SE
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
SLB.N SCHLUMBERGER NV
RI PERNOD RICARD SA
GTT GAZTRANSPORT & TECHNIGAZ SA
SBMO SBM OFFSHORE NV
EURN EURONAV NV
ADEN ADECCO GROUP AG
PGS PGS ASA
ZAL ZALANDO SE
ENI ENI S.P.A.
P2F PETROFAC LIMITED
REP REPSOL SA
SOC SUBSEA 7 S.A.
SBO SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG
EVK EVONIK INDUSTRIES AG
TRE TECNICAS REUNIDAS SA
DR0 DEUTSCHE ROHSTOFF AG
TEC TECHNIPFMC PLC
BP. BP P.L.C.
CGG CGG
ENOG ENERGEAN PLC
VK VALLOUREC SA
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
TE TECHNIP ENERGIES NV
FUR FUGRO NV
SHEL SHELL PLC
SPM SAIPEM S.P.A.
TEN TENARIS S.A.
- Oliver Metzger
SARTORIUS AG : Taking a turn for the better, destocking to end, guidan...
Sartorius is set to outperform the underlying biopharmaceutical market based on higher exposure to novel biologics and its focus on single-use components. Destocking is likely to end soon but the changing ordering pattern could distort order intake as KPI and organic growth should recover faster. In our view, the expected cut to its FY 2024 guidance is already largely reflected in the share price. Based on the expected turnaround, we have upgraded to Outperform with a new target ...
- Geoffroy Michalet
Eurofins : Eurofins réfute les accusations de MW…qui sort un second ra...
>Des éléments complémentaires fournis par Eurofins concernant l’immobilier … - Eurofins a publié hier un rapport détaillé pour répondre aux accusations de Muddy Waters réparti en 13 parties... ainsi que des liens vers de nombreuses données pour étayer les propos. Nous nous concentrons sur les éléments les plus importants, l'immobilier, la trésorerie et la comptabilité. Les transactions immobilières : Le groupe a précisé que 13.9% de l’immobilier, soit 240 km...
Mercialys : Informations relatives au nombre total de droits de vote e...
PARIS--(BUSINESS WIRE)-- Regulatory News: Mercialys (Paris:MERY): Nombre d’actions composant le capital Nombre total de droits de vote Nombre total de droits de vote exerçables en assemblée générale 93 886 501 93 886 501 93 448 370 * * * * Paris, le 3 juillet 2024 à 16h Consultez la version source sur businesswire.com :
- Thomas J. Schiessle
CEO verlängert nicht über Nov. 2025 hinaus - Q1/24 dokumentierte opera...
Nach knapp 20 Jahren als hat CEO Dr. Joachim Kreuzburg angekündigt – aus Gründen der persönlichen Lebensplanung - keine nochmalige Vertragsverlängerung - über den 30.11.25 hinaus – anzustreben; er strebe ferner keine operative Position in einem anderen Unternehmen an. Die Ankeraktionäre werden nun wichtig: Seit in 2023 ist Bio-Rad Laboratories Inc. Aktionär (derzeit Anteil an Ord. 28%; Pref: 38%). Durch Lothar Kappich (SRT-AR-Vorsitz) wird die Horst Sartorius Erbengemeinschaft in Höhe von 50,0...
- Carole Braudeau
- Thomas J. Schiessle
CEO will not extend beyond Nov. 2025 - Q1/24 documented operational tu...
After almost 20 years as CEO, Dr Joachim Kreuzburg has announced - for reasons of personal life planning - that he will not seek a further contract extension beyond 30.11.2025; furthermore, he will not seek an operational position in another company. The anchor shareholders are now becoming important: Bio-Rad Laboratories Inc. has been a shareholder since 2023 (current share in Ord. 28%; Pref: 38%). Lothar Kappich (SRT-SB-Chairman) represents the Horst Sartorius community of heirs in the amount ...
- Carole Braudeau
Clariane annonce le succès de son augmentation de capital avec maintie...
PARIS--(BUSINESS WIRE)-- Regulatory News: NE PAS DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS D’AMERIQUE, AU CANADA, EN AUSTRALIE OU AU JAPON. LE PRESENT COMMUNIQUE NE CONSTITUE PAS UNE OFFRE DE VALEURS MOBILIERES AUX ÉTATS-UNIS D’AMERIQUE OU DANS UN TOUT AUTRE PAYS. LE PRESENT COMMUNIQUE CONSTITUE UNE COMMUNICATION A CARACTERE PROMOTIONNEL ET NON PAS UN PROSPECTUS AU SENS DU REGLEMENT (UE) 2017/1129. Clariane (Paris:CLARI) (CLARIA.PA – ISIN FR0010386334) (la « Société ») annonce aujourd’hui le succès de son augmentation de capital avec maintien du droit préférentiel de sousc...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.